483 KATALYST Mar 2019

483 KATALYST Mar 2019

Christopher Genther FDA$119.00 - Available Now

FDA investigators audited the KATALYST - Seattle, WA, United States facility and issued inspectional observations (via FDA 483) on 28 Mar 2019.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 28 Mar 2019
  • Location: Seattle, United States
  • FEI: 3014545203
Add To Cart